The Ark
A blog about our science, the rare disease community and PerlQuests
Perlara and Global Genes host World Rare Disease Day event
On March 1, 2018, Perlara PBC and Global Genes hosted an event in honor of World Rare...
Economies of Rare
Economies of scale are the efficiencies unlocked by large numbers. I’ve come to...
Perlara celebrates International Women’s Day 2018
Women in science Women have made invaluable contributions to science from the...
Our 2017 Benefit Corporation Report
Today is Perlara's birthday — 4 years old! As the first biotech public benefit...
A chemical modifier screen for PMM-2 deficiency in worms
Perlara and Maggie’s Cure have started a PerlQuest for a glycosylation disorder...
New NGLY1 preprint
On the first day of the new year, we submitted a new NGLY1 model preprint titled...
Developmental delay and movement defects in a worm model of Niemann-Pick Type A disease
In December of 2016, Perlara partnered with Wylder Nation to initiate an NPA...
Yeast models of PMM2 deficiency, a congenital disorder of glycosylation
A goal of Stage 1 of our PMM2-CDG PerlQuest with Maggie’s Cure is to identify yeast...
Acid sphingomyelinase (ASM) deficiency in Drosophila causes early larval lethality
A few months ago, Taryn Sumabat blogged about development of a fly model of a...
Fly models of NGLY1 Deficiency
Earlier this week I was alerted on Twitter (where else?) to a new NGLY1 paper from...
Perlara Open Finances 2017
When we last checked in a year ago, Perlara had just achieved three critical...
Finding the right marker for Mucolipidosis Screen
The Condition: Mucolipidosis Type IV Mucolipidosis is a group of inherited lysosomal...
